By Gwyneth Astles
BRINGING YOU THE LATEST NEWS & EVENTS FROM THE SCIENCE INDUSTRY
New spatial biology platform launches at UCLA accelerator
Meteor Biotech, a leading developer of spatial omics technology and region-targeted cell sorting devices, has announced the installation of its next-generation spatial biology platform, CosmoSort, at Magnify, the California NanoSystems Institute (CNSI) incubator at UCLA. The site also marks the opening of Meteor Biotech’s newly established US offi ce. Situated at the heart of UCLA’s campus, Magnify offers high-quality, affordable facilities, expert services, and a vibrant innovation ecosystem to help transformative technology startups thrive.
With CosmoSort now operational at Magnify, Meteor Biotech is ready to welcome researchers and drug developers from across the United States. Scientists working in oncology, neurology, immunology, and biomarker discovery can now access the company’s proprietary Spatially- Resolved Laser-Activated Cell Sorting (SLACS) technology for advanced single-cell analysis.
Unlike conventional spatial omics platforms that primarily chart expression profi les across tissue samples, SLACS enables researchers to isolate and extract specifi c cells from
tissue sections with unprecedented speed and accuracy, allowing for far deeper and more detailed analyses.
“Meteor Biotech is excited to establish our new offi ce at the Magnify Incubator,” said Dr Amos Lee, co-founder and CEO of Meteor Biotech. “This milestone represents a signifi cant step in our growth and reinforces our commitment to innovation and collaboration within the CNSI ecosystem. By installing CosmoSort, we are providing researchers with unparalleled single-cell analysis capabilities, and we anticipate this will accelerate breakthrough discoveries. The alignment between our mission and Magnify’s vision for supporting transformative startups makes this partnership an ideal fi t.”
Academic scientists and drug developers will be able to take part in hands-on trials, demonstrations, and pilot studies using CosmoSort. Meteor Biotech will also provide on-site trials and customer training to ensure optimal use of the technology.
Dr Amos Lee. Credit: Meteor Biotech
“Magnify is thrilled to welcome Meteor Biotech to our incubator,” said Nikki Lin, Director of the Magnify Incubator at CNSI. “Their decision to establish a US offi ce here and make advanced scientifi c equipment accessible refl ects the collaborative and innovative environment we aim to cultivate.
Academic scientists and drug developers will be able to take part in hands-on trials, demonstrations, and pilot studies.
By providing researchers with cutting-edge tools, Meteor Biotech is not only strengthening our ecosystem but also contributing to the broader scientifi c community. Together, we look forward to driving impactful advances in biotechnology and fostering a culture of innovation and excellence.”
More information online:
ilmt.co/PL/Jd2b 65736pr@reply-direct.com
Unravelling the structure of future solar cell materials
Researchers at Chalmers University of Technology, Sweden, have shed light on a long-standing mystery surrounding one of the most promising materials for future solar cells – formamidinium lead iodide, a member of the halide perovskite family.
Halide perovskites are considered strong candidates for next-generation solar cells and optoelectronics, thanks to their ability to absorb and emit light with high effi ciency. However, their commercial use has been hampered by instability and a lack of detailed understanding of their atomic-scale structure and dynamics.
Using advanced computer simulations combined with machine learning, the Chalmers team has now identifi ed the structure of formamidinium lead iodide at low temperatures. Their work resolves a ‘missing piece’ in the research puzzle by showing how formamidinium molecules settle into a semi-stable state during cooling.
The breakthrough, published in the Journal of the American Chemical Society [1], brings researchers closer to engineering perovskite materials that are both effi cient and stable. To validate the simulations, the team collaborated with experimental researchers at the University of Birmingham, who confi rmed the fi ndings by cooling the material to –200°C.
“Our fi ndings provide essential insights for engineering and controlling one of the most promising solar cell materials,” said Associate Professor Julia Wiktor. “The advanced simulation methods we now have can answer questions that were unresolved just a few years ago.”
Julia Wiktor. Credit: Chalmers / Anna-Lena Lundqvist
As global electricity demand rises, more effi cient solar technologies are urgently needed. Understanding and
Formamidinium lead iodide is considered one of the best- performing materials in the halide perovskite group, since it has promising properties for future solar cell technologies. New fi ndings from Chalmers can now shed light on its structure; this is crucial if we are to engineer and control the material. Chalmers University of Technology
controlling perovskite structures could pave the way for lightweight, fl exible solar cells capable of powering everything from mobile devices to buildings.
More information online:
ilmt.co/PL/YeWE
1. Revealing the Low-Temperature Phase of FAPbI3 Using a Machine- Learned Potential published in Journal of the American Chemical
65849pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
